447. Reduction of Sensory Reactivity Symptoms Corresponds to Improved Psychiatric Symptoms in an Open-Label Study of Low-Dose Ketamine in Children With ADNP Syndrome

• DOI: 10.1016/j.biopsych.2023.02.687
• Publication Date: 2023-04-10T10:35:12Z
• Authors: Arabella Peters; Tess Levy; Jadyn Trayvick; Christina Layton; Sarah Barkley; Bonnie Lerman; Hannah Walker; Katherine Keller; Jessica Zweifach; Danielle Halpern; Paige Siper; Joseph Buxbaum; Jennifer Foss-Feig; Alexander Kolevzon
• Keywords: Fragile X Syndrome; Open label; Neurodevelopmental disorder